HomeMy WebLinkAboutResolution No. 198-25 - Resolution - Approving Opioid Settlement
RESOLUTION _______
Authorizing Participation In Current and Future National Prescription Opioid
Settlements.
WHEREAS, the State of Minnesota and numerous Minnesota cities and counties, have
continued to engage in nationwide civil litigation against opioid supply chain participants,
related to the opioid crisis (“Prescription Opioid Litigation”); and
WHEREAS, the Minnesota Attorney General has signed on to multistate settlement
agreements with several opioid supply chain participants, but those settlement
agreements are still subject to sign-on by local governments and final agreement by the
companies and approval by the courts; and
WHEREAS, in May 2019, the City of Rochester filed its own lawsuit against
manufacturers and distributors of prescription opioids (Case No. 0:19-cv-01317, MDL No.
1:17-MD-2804) and joined the Prescription Opioid Litigation; and
WHEREAS, state governments previously negotiated nation-wide settlements with
numerous defendants, with the settlements approved by the Rochester Common Council
in December of 2021, with anticipated settlement proceeds for the City of Rochester
jurisdiction of approximately $2.7M over a 15-year period of time; and
WHEREAS, state governments continued to negotiate with additional defendants and
have now reached agreements with Purdue Pharma & Sackler Family (hereinafter,
“Purdue Pharma”) as well as a group of additional defendants including Alvogen, Amneal,
Apotex, Hikma, Indivior, Mylan, Sun, and Zydus (hereinafter, “Alvogen.”); and
WHEREAS, representatives of Minnesota’s local governments, the Office of the Attorney
General, and the State of Minnesota previously reached agreement on the intrastate
allocation of these settlement funds between the State, and the counties and cities, as
well as the permissible uses of these funds, memorialized in the Minnesota Opioids State-
Subdivision Memorandum of Agreement (the “State-Subdivision Agreement”); and
WHEREAS, the State-Subdivision Agreement creates an opportunity for local
governments and the State to work collaboratively on a unified vision to deliver a robust
abatement and remediation plan to address the opioid crisis in Minnesota; and
WHEREAS, as a litigating entity, the City of Rochester is entitled to receive funds under
the Opioid Litigation Settlements; and
WHEREAS, it is in the best interests of the State of Minnesota and the residents of the
City of Rochester and Olmsted County that the City participate in the Opioid Litigation
Settlements.
1
219505v1
NOW, THEREFORE, BE IT RESOLVED, by the Common Council of the City of
Rochester, Minnesota:
1. Participation in the Opioid Litigation Settlements promotes the public health,
safety, and welfare of the residents of the City of Rochester; and
2. The City of Rochester supports and opts-in to the Opioid Litigation
Settlements with the Settling Distributors Purdue Pharma and Alvogen, as
well as all future multistate settlement agreements with opioid supply chain
participants; and
3. City Staff is hereby authorized to execute or ensure execution of all
necessary documents to ensure City participation in the above referenced
Opioid Litigation Settlements, as well as all future multistate settlement
agreements, including the Participation Agreement and accompanying
Release, and the State-Subdivision Agreement.
PASSED AND ADOPTED BY THE COMMON COUNCIL OF THE CITY OF
ROCHESTER, MINNESOTA, THIS ______ DAY of ____________, 2025.
________________________________
PRESIDENT OF SAID COMMON COUNCIL
ATTEST:________________________________
CITY CLERK
APPROVED THIS ______ DAY of ____________, 2025.
________________________________
MAYOR OF SAID CITY
(Seal of the City of
Rochester, Minnesota)
Res25\\AcceptOpioidSettlements.docx
2
219505v1